Age and apoE associations with complex pathologic features in Alzheimer's disease

scientific article published on 23 July 2008

Age and apoE associations with complex pathologic features in Alzheimer's disease is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.JNS.2008.06.008
P932PMC publication ID2569823
P698PubMed publication ID18653200
P5875ResearchGate publication ID51426629

P50authorDennis W. DicksonQ30504740
Ronald C. PetersenQ56839853
David S KnopmanQ63967707
Joseph E ParisiQ67209577
Bradley F BoeveQ67501037
Gregory A JichaQ92594727
Ruth H ChaQ114336674
Glenn E. SmithQ46205917
P2093author name stringKris A Johnson
P2860cites work“Mini-mental state”Q25938989
Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's DiseaseQ27860795
Neuropathological stageing of Alzheimer-related changesQ27860862
Convergence of atherosclerosis and Alzheimer's disease: inflammation, cholesterol, and misfolded proteinsQ28168105
APOE genotype effects on Alzheimer's disease onset and epidemiologyQ28265282
The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's diseaseQ29614948
The Clinical Dementia Rating (CDR): current version and scoring rulesQ29616280
Vascular pathologies and cognition in a population-based cohort of elderly peopleQ30975914
Alpha-synuclein pathology does not predict extrapyramidal symptoms or dementiaQ33340612
Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS).Q33935314
Age-associated prevalence and risk factors of Lewy body pathology in a general population: the Hisayama studyQ34220529
The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part X. Neuropathology confirmation of the clinical diagnosis of Alzheimer's diseaseQ34321510
Mayo Clinic Alzheimer's Disease Patient Registry.Q52054751
Alzheimer's disease with and without coexisting Parkinson's disease changes: apolipoprotein E genotype and neuropathologic correlates.Q53199687
The apolipoprotein E allele epsilon 4 is overrepresented in patients with the Lewy body variant of Alzheimer's disease.Q53204624
Neuropathology in controls and demented subjects from the Baltimore Longitudinal Study of Aging.Q53212473
Vascular risks and incident dementia: results from a cohort study of the very old.Q53223154
Accuracy of clinical criteria for AD in the Honolulu-Asia Aging Study, a population-based study.Q53243175
Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the Consortium on DLB International Workshop.Q55042329
Cortical and subcortical argyrophilic grains characterize a disease associated with adult onset dementiaQ69072601
The importance of cerebral lesions of vascular origin in the morphopathologic picture of old age dementiaQ69731229
Diagnosis of Alzheimer's diseaseQ69871134
Prevalence of cerebral vascular amyloid-beta deposition and stroke in an aging Australian population: a postmortem studyQ73127224
Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's DiseaseQ73789480
Lewy body-related alpha-synucleinopathy in agingQ80410949
Statins, incident Alzheimer disease, change in cognitive function, and neuropathologyQ80503048
Staging of argyrophilic grains: an age-associated tauopathyQ80797442
Pathologic correlates of nondemented aging, mild cognitive impairment, and early-stage Alzheimer's diseaseQ34509732
Genetic association between the APOE*4 allele and Lewy bodies in Alzheimer disease.Q34709035
Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshopQ34736093
Mixed dementia: epidemiology, diagnosis, and treatmentQ34775417
Dementia epidemiologyQ34777681
Stroke epidemiology: a review of population-based studies of incidence, prevalence, and case-fatality in the late 20th centuryQ35172345
Dementia with Lewy bodies according to the consensus criteria in a general population aged 75 years or olderQ35474145
Genetic risk factors for stroke and carotid atherosclerosis: insights into pathophysiology from candidate gene approachesQ35708128
Atherosclerotic Vascular Disease Conference: Writing Group I: epidemiologyQ35789818
Alzheimer's disease is a vasocognopathy: a new term to describe its natureQ35841706
Pathogenic factors in vascular dementia and Alzheimer's disease. Multiple actions of heparin that probably are beneficialQ35852208
Neurodegenerative diseases: insights into pathogenic mechanisms from atherosclerosisQ36003471
Argyrophilic grain disease: a late-onset dementia with distinctive features among tauopathiesQ36004991
Cerebrovascular disease and the pathophysiology of Alzheimer's disease. Implications for therapy.Q36118169
Applicability of current staging/categorization of alpha-synuclein pathology and their clinical relevanceQ36501660
Assessing the cognitive impact of Alzheimer disease pathology and vascular burden in the aging brain: the Geneva experienceQ36621520
Neuropathological aspects of Alzheimer disease, Parkinson disease and frontotemporal dementiaQ37102977
Neuropathology of older persons without cognitive impairment from two community-based studiesQ38405842
Argyrophilic grain disease is a sporadic 4-repeat tauopathyQ39527344
Brain infarction and the clinical expression of Alzheimer disease. The Nun StudyQ42435324
The Lewy body variant of Alzheimer's disease: a clinical and pathologic entityQ42479244
Risk factors for cerebral amyloid angiopathy in the elderlyQ43519767
Incidence of stroke in relation to cognitive function and dementia in the Kungsholmen ProjectQ44705300
The incidence of dementia: a meta-analysisQ45174488
The apolipoprotein E epsilon 4 allele is associated with increased neuritic plaques and cerebral amyloid angiopathy in Alzheimer's disease and Lewy body variantQ46323718
Mixed brain pathologies account for most dementia cases in community-dwelling older personsQ48136681
Clinico-neuropathological correlation of Alzheimer's disease in a community-based case seriesQ48212849
Accumulation of phosphorylated alpha-synuclein in aging human brainQ48266774
Neuropathology of white matter changes in Alzheimer's disease and vascular dementia.Q48406159
Alzheimer's disease and brain infarcts in the elderly. Agreement with neuropathologyQ48452142
Neuropathologic evidence that the Lewy body variant of Alzheimer disease represents coexistence of Alzheimer disease and idiopathic Parkinson diseaseQ48463134
Postmortem MRI and histopathology of white matter changes in Alzheimer brains. A quantitative, comparative studyQ48608182
Increased frequency of argyrophilic grain disease in Alzheimer disease with 4R tau-specific immunohistochemistryQ48946568
Lewy body-related alpha-synucleinopathy in the aged human brain.Q50282783
Apolipoprotein E status as a predictor of the development of Alzheimer's disease in memory-impaired individuals.Q51125007
Vascular Dementia in a Population-Based Autopsy StudyQ51949169
Mild cognitive impairment in the oldest old.Q51950636
P433issue1-2
P921main subjectAlzheimer's diseaseQ11081
P304page(s)34-39
P577publication date2008-07-23
P1433published inJournal of the Neurological SciencesQ6296168
P1476titleAge and apoE associations with complex pathologic features in Alzheimer's disease
P478volume273

Reverse relations

cites work (P2860)
Q35231770Alzheimer's disease is not "brain aging": neuropathological, genetic, and epidemiological human studies
Q36175429Antemortem Prediction of Braak Stage
Q36395714Brain pathologies in extreme old age.
Q24599735Conceptual evolution in Alzheimer's disease: implications for understanding the clinical phenotype of progressive neurodegenerative disease
Q35529951Neuropathologic features associated with Alzheimer disease diagnosis: age matters
Q35633470Preclinical AD Workgroup staging: pathological correlates and potential challenges.
Q64269936Primary Age-Related Tauopathy: An Elderly Brain Pathology Frequently Encountered during Autopsy
Q36862597Substantia nigra depigmentation and exposure to encephalitis lethargica.
Q34550595Tau aggregation influences cognition and hippocampal atrophy in the absence of beta-amyloid: a clinico-imaging-pathological study of primary age-related tauopathy (PART).
Q91451096Tau and TDP-43 proteinopathies: kindred pathologic cascades and genetic pleiotropy
Q36957279The occurrence of cerebrovascular atherosclerosis in Alzheimer's disease patients
Q47907796Vascular Contributions in Alzheimer's Disease-Related Neuropathological Changes: First Autopsy Evidence from a South Asian Aging Population

Search more.